The organization Demokraci Plus (D+) released an analysis titled “Transparency and the Implementation of Drug Price Regulation in Kosovo,” which assesses the progress of establishing uniform drug prices throughout the country’s pharmacies. The study notes that the passage of the relevant legislation was a necessary measure, given that for more than two decades, citizens encountered varying prices for identical medicinal products. Furthermore, the analysis points out instances where public institutions purchased pharmaceuticals at rates exceeding prevailing market prices.
Despite the legislative necessity, D+ assesses that the actual implementation of the reform has been hampered by insufficient institutional capacities. While the law officially took effect in 2023, the formal Official List of Prices was not scheduled for implementation until February 2025. The analysis underscores that this extended transition period has been a critical factor in the process.
The core objective of the regulation is to ensure price parity, thereby protecting consumers from financial discrepancies when purchasing necessary medications. The findings suggest a gap between legislative approval and operational reality regarding the stabilization of drug prices. The report highlights the importance of robust institutional frameworks to ensure that the established price controls are uniformly and effectively applied across all retail sectors.
Ultimately, the analysis calls attention to the challenges inherent in transitioning from disparate pricing structures to a standardized system of medicine prices.
Topics: #prices #demokraci #plus
